Oracle Health Sciences has developed a new solution allowing clinical trial teams to remotely conduct trials by collecting e-Source data from the patient’s sensors, wearables and apps.
The new mHealth Connector Cloud Service is capable of connecting existing clinical systems with various e-Sources, enabling therapeutic teams to obtain more accurate and rich patient data, as well as improve adherence to study protocols.
It also aids an understanding of the safety and efficacy of trial drugs, as well as improving patient centricity with remote patient monitoring.
The solution supports several integration approaches and will make use of Oracle Health Sciences’ ongoing efforts to explore integration. The latter uses a variety of mobile health companies’ ecosystems such as Validic, MC10 and CMT, as well as solution integrators and developers, including Accenture and POSSIBLE Mobile.
Oracle Health Sciences general manager Steve Rosenberg said: “What used to be patient-recorded data and outcomes via paper forms and site visits can now be done via mobile health sensors and wearables that have the potential to shorten trial times and reduce costs, while allowing sick patients to remain in the comfort of their homes versus travelling to and from trial sites.
“To improve patient enrolment in clinical trials, study teams must put the patient at the centre of everything they do, and emerging technologies such as wearables and sensors hold the key.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Oracle Health Sciences is a set of software developed by Oracle and is designed to create clinical trials and conduct pharmacovigilance based on the database created with it.